A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer. Mineva, N. D, Pianetti, S., Das, S. G, Srinivasan, S., Billiald, N. M, & Sonenshein, G. E Pharmaceutics, 16(4):536, MDPI, 2024.
bibtex   
@article{mineva2024novel,
  title={A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer},
  author={Mineva, Nora D and Pianetti, Stefania and Das, Sonia G and Srinivasan, Srimathi and Billiald, Nicolas M and Sonenshein, Gail E},
  journal={Pharmaceutics},
  volume={16},
  number={4},
  pages={536},
  year={2024},
  publisher={MDPI}
}

Downloads: 0